Vanguard Group Inc Evolus, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EOLS
# of Institutions
169Shares Held
48.8MCall Options Held
57.2KPut Options Held
5.5K-
Perceptive Advisors LLC New York, NY5.15MShares$73.7 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$71.6 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$57.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$44.8 Million1.74% of portfolio
-
State Street Corp Boston, MA1.42MShares$20.4 Million0.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $803M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...